Protein carbonylation as a possible way to modulate breast cancer cell proliferation

Introduction. High rates of cancer incidence and mortality worldwide dictate the necessity of developing new methodological approaches in understanding the molecular mechanisms of cancer progression associated with intracellular redox regulation imbalance.

The objective of the study was to evaluate the role of protein carbonylation in regulating breast cancer cell proliferation under redox status modulation.

Materials and Methods. In the intact breast cancer cells and in the cells cultured under redox status modulation using 5mM N-ethylmaleimide (an - SH group blocker) and 5 Mm 1,4-dithioerythritol (a thiol group protector), the concentration of thioredoxin and its carbonylated form was measured using Western blot analysis. The activity of thioredoxin reductase and the level of protein carbonyl derivatives were determined using spectrophotometry. Cell cycle phase distribution was evaluated by flow cytometry.

Results and Discussion. Under the effect of N-ethylmaleimide, cell cycle arrest in the S-phase was confirmed by oxidative modification of proteins, including thioredoxin carbonylation. When culturing MCF-7 cells in the presence of 1,4-dithioerythritol, cell cycle arrest in the G0/G1 phases was associated with a rise in the concentrations of reduced thioredoxin and glutathione forms.

Conclusion. The thioredoxin system and oxidative modification of proteins are involved in redox-dependent modulation of breast cancer cell proliferation. Studies in the area of redox proteomics offer great potential to seek molecular targets of malignant transformation of breast cells.

1. Healthcare in Russia. 2017: A statistical compilation. Moscow: Rosstat; 2017. 170. (in Russian).

2. Eaton P. Protein thiol oxidation in health and disease: techniques for measuring disulfides and related modifications in complex protein mixtures. Free Radic. Biol. Med. 2006; 40 (11): 1889-99. doi: 10.1016/j. freeradbiomed.2005.12.037.

3. ButterfieldD.A., Dalle-Donne I. Redox proteomics: from protein modifications to cellular dysfunction and disease. Mass Spectrom. Rev. 2014; 33 (1): 1-6. doi: 10.1002/mas.21404.

4. Clementino M., Shi X., Zhang Z. Oxidative stress in carcinogenesis. Current Opinion in Toxicology. 2018; (7): 116-121. doi: 10.1016/j.cotox.2017.11.014.

5. MenshchikovaE.B., ZenkovN.K., Lankin V.Z., Bondar I.A., Trufakin VA. Oxidative stress: Pathological conditions and diseases. Novosibirsk, 2008. 284. (in Russian).

6. Brigelius-FloheR., FloheL. Basic principles and emerging concepts in the redox control of transcription factors. Antioxid Redox Signal. 2011; 15 (8): 2335-2381. doi:10.1089/ars.2010.3534.

7. Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr. Rev. 2012; 70 (5): 257-265. doi: 10.1111/j.1753-4887.2012.00476.x.

8. Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012; 24 (5): 981-990. doi: 10.1016/J.CELLSIG.2012.01.008.

9. ZenkovN.K., Kozhin PM., Chechush-kov A.V, Martinovich G.G., Kandalintseva N.V, Menshchikova E.B. Labyrinths of regulation Nrf2. Biochemistry. 2017: 82 (5): 749-759. (in Russian).

10. Kalinina E.V, ChernovN.N., SaprinA.N. Participation of thio-, peroxy- and glutaredoxins in redox-dependent cellular processes. Advances in biological chemistry. 2008; 48: 319-358. (in Russian).

11. Harris I.S., Treloar A.E., Inoue S., SasakiM., Gorrini C., Lee K. C., Yung K.Y., Brenner D., Knobbe-Thomsen C.B., Cox MA., Elia A., Berger T., CesconD. W.,AdeoyeA.,BrustleA.,MolyneuxS.D.,MasonJ.M.,Li W.Y., Yamamoto K., WakehamA., BermanH.K., KhokhaR., DoneS.J., Kavanagh T.J., Lam C. W., Mak T. W. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell. 2015; 27 (2): 211-22. doi: 10.1016/j.ccell.2014.11.019.

12. YaoP., ChenX., Yan Y, LiuF, Zhang Y., GuoX., XuB. Glutaredoxin 1, glutaredoxin 2, thioredoxin 1, and thioredoxin peroxidase 3 play important roles in antioxidant defense in Apis cerana cerana. Free Radic Biol Med. 2014 Mar; 68: 335^6. doi: 10.1016/j.freeradbiomed.2013.12.020.

13. Sahaf B., Heydari K., Herzenberg LA. Lymphocyte surface thiol levels. Proc Natl Acad Sci USA. 2003; 100 (7): 4001-05.

14. Brunelli L., Crow J.P., Beckman J.S. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli. Arch Biochem Biophys. 1995 Jan 10; 316 (1): 327-34.

15. Shakhristova E.V, Stepovaya E.A., Rudikov E.V, Novitsky V.V; Siberian State Medical University. The method for determining the oxidative modification of thioredoxin. Patent No. 2651765 Russian Federation: IPC G01N 33/53. № 2017118698/15; Claims 05.29.2017; Publ. 04.23.2018 Byul. No 12. (in Russian).

16. Tamura T., Stadtman T.C. A new selenoprotein from human lung adenocarcinoma cells: рurification, properties, and thioredoxin reductase activity. Proc Natl Acad Sci USA. 1996 Feb 6; 93 (3): 1006-11.

17. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7; 72: 248-54.

18. Arutunyan A.V, Dubinina E.E., Zybina N.N. Methods for evaluating free radical oxidation and antioxidant protection of the body. Saint-Peterburg, 2000. 103. (in Russian).

19. Murphy M.P., Holmgren A., Larsson N.G., Halliwell B., Chang CJ., Kalyanaraman B., Rhee S.G., Thornalley P.J., Partridge L., Gems D., Nystrom T., Belousov V, Schumacker P.T., Winterbourn C.C. Unraveling the biological roles of reactive oxygen species. Cell Metab. 2011; 13 (4): 361-366. doi: 10.1016/j.cmet.2011.03.010.

20. Shakhristova E.V, Stepovaya EA., RyazantsevaN.V, Nosareva O.L., Yakushina VD., Ivanov V.V, Novitsky V.V. The role of the redox potential of the glutathione system in the dysregulation of apoptosis of MCF-7 breast adenocarcinoma cells. Bulletin of experimental biology and medicine. 2015; 160 (9): 351-354. (in Russian).

21. Stepovaya EA., Shakhristova E.V, Ryazantseva N.V, Nosareva O.L., Chil’chigashev R.I., Egorova M.Y. The thioredoxin system in regulating MCF-7 cell proliferation under redox status modulation. Siberian journal of oncology. 2016; 15 (4): 50-55. (in Russian). doi: 10.21294/1814-4861-2016-15-4-50-55.

22. Wong C.M., Bansal G., Marcocci L., Suzuki YJ. Proposed role of primary protein carbonylation in cell signaling. Redox Rep. 2012; 17 (2): 90-94. doi: 10.1179/1351000212Y.0000000007.

23. Burch PM., Heintz N.H. Redox regulation of cell-cycle re-entry: cyclin D1 as a primary target for the mitogenic effects of reactive oxygen and nitrogen species. Antioxid Redox Signal. 2005; 7 (5-6): 741-751. doi: 10.1089/ars.2005.7.741.